Clinical Trials Logo

Staphylococcal Sepsis clinical trials

View clinical trials related to Staphylococcal Sepsis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04886284 Recruiting - Clinical trials for Staphylococcus Aureus Bacteremia

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

CERT
Start date: May 20, 2024
Phase: Phase 2
Study type: Interventional

There is a variety of in vitro, in vivo (animal model), and human case series data which suggests that the addition of ertapenem to cefazolin could improve outcomes in methicillin-susceptible S. aureus bacteremia. No randomized controlled trial has been performed. This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform (SNAP) trial (NCT05137119)